Previous 10 | Next 10 |
Leading endocrinology and metabolism academic expert with research focus in pathophysiology and treatment of obesity and type 2 diabetes Robust business development initiative to build biopharmaceuticals pipeline underway with expectation to announce at least one in-licensing agree...
Presentation with Live Audio Webcast Tuesday, September 17th at 10:00 AM ET BEVERLY HILLS, CA / ACCESSWIRE / September 10, 2019 / Applied BioSciences Corp. (OTCQB:APPB) ("Applied" or the "Company"), a vertically integrated company focused on the development of science-driven cannab...
Trace Analytics Inc. is a Leading Cannabis Science and Technology Company with Significant Footprints in Lab Testing, Research and Development and Licensing BEVERLY HILLS, CA / ACCESSWIRE / August 27, 2019 / Applied BioSciences Corp. (OTCQB:APPB) ("Applied" or the "Company")...
Applied Biosciences ( OTCQB:APPB ): Q1 GAAP EPS of -$0.03. More news on: Applied Biosciences Corp., Earnings news and commentary, , Read more ...
– Quarter marked by reinvigorated focus on purposefully built strategic business units leveraging science-driven cannabinoid research to address areas of significant unmet needs and access growing markets – – Robust business development initiative to build biopharm...
APPB has a Differentiated Portfolio of Science-Driven CBD Products and is Actively Building a Robust Biopharmaceuticals Pipeline in High-Value Indications PHOENIX, AZ / ACCESSWIRE / August 1, 2019 / The Stock Day Podcast announced the launch of a recent interview...
Key Management appointments, including Raymond W. Urbanski MD, PhD, former business unit Chief Medical Officer at Pfizer Inc., as Chief Executive Officer provides extensive industry leading expertise, strategic focus and discipline on the execution of corporate initiatives Purp...
Los Angeles, California--(Newsfile Corp. - July 24, 2019) - Applied BioSciences Corp. (OTCQB: APPB), a vertically integrated company focused on the development of science-driven cannabinoid biopharmaceuticals and the production of high-quality CBD products, as well as testing and analytics, an...
Los Angeles, CA, June 06, 2019 (GLOBE NEWSWIRE) -- Applied Biosciences Corp. ( OTC: APPB ), a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, announced that has officially launched its Champ Organics product line ...
LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on the medical, biopharmaceutical testing, consumer and veterinary health industries, announced today the appointment of Dr. Raymond W. U...
News, Short Squeeze, Breakout and More Instantly...
Applied BioSciences Corp Company Name:
APPB Stock Symbol:
OTCMKTS Market:
Applied BioSciences Corp Website:
Los Angeles, CA, April 27, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that tar...
Los Angeles, CA, April 24, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that tar...
LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / Applied BioSciences Corp. (OTCQB:APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to ...